First Food and Drug Administration approval under humanitarian device exemption of a septal occluder for fenestrated fontan and muscular ventricular septal defects.

C. E. Ruiz, E. H. Austin, J. P. Cheatham, D. A. Danford, L. A. Latson, J. Mayer, C. E. Mullins, S. Sanders

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)E9042
Issue number21
StatePublished - May 30 2000

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this